NAPA, Calif., March 6 /PRNewswire-FirstCall/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged in the development of technologies that target the science of healthy aging, today announced that the Company has brought on two Veteran Sales and Marketing Executives, and the appointment of a Vice President of Communications.
Michael Campagnoli joined the Company in December and has been appointed Executive Director. In addition, Phillip Rose has been retained as Consultant for Sales and Marketing. Both men will be involved in the commercialization of Senetek's proprietary technology, and will oversee product marketing collaborations for the Company.
Michael Campagnoli began his pharmaceutical career at Pfizer Corporation before joining GlaxoSmithKline as Marketing Manager. At PediaMed Pharmaceuticals, Mr. Campagnoli was National Sales and Marketing Manager and later assumed the position of Director of Business Development. Most recently, Mr. Campagnoli was the Executive Director of Sales and Business Development for PARI Pharma, a Virginia-based specialty pharmaceutical company. He is a graduate of Western Maryland College and holds a Masters from the University of Maryland.
Mr. Campagnoli stated, "I am pleased to be a part of the Senetek team at this important time when we are poised to accelerate the commercialization of the Company's technology."
Phillip Rose has thirty years of experience in domestic and
international sales, marketing, commercial development, licensing,
regulatory affairs and general executive management of large public and
multi-national pharmaceutical research, development and sales and marketing
organizations. For nine years, Mr. Rose was Vice President of Corporate
Sales for Glaxo Pharmaceuticals, Inc. In 1997 he became Vice President and
General Manager of North American Operations for ICN Pharmaceuticals, Inc.
(now Valeant Pharmaceuticals). He then went on to become President and CEO
|SOURCE Senetek PLC|
Copyright©2008 PR Newswire.
All rights reserved